Titre : Épilepsie partielle sensorielle

Épilepsie partielle sensorielle : Questions médicales fréquentes

Termes MeSH sélectionnés :

Probability
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Épilepsie partielle sensorielle : Questions médicales les plus fréquentes", "headline": "Épilepsie partielle sensorielle : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Épilepsie partielle sensorielle : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-02-07", "dateModified": "2025-05-02", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Épilepsie partielle sensorielle" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Épilepsies partielles", "url": "https://questionsmedicales.fr/mesh/D004828", "about": { "@type": "MedicalCondition", "name": "Épilepsies partielles", "code": { "@type": "MedicalCode", "code": "D004828", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C10.228.140.490.360" } } }, "about": { "@type": "MedicalCondition", "name": "Épilepsie partielle sensorielle", "alternateName": "Epilepsy, Partial, Sensory", "code": { "@type": "MedicalCode", "code": "D020937", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Xiao-Rong Liu", "url": "https://questionsmedicales.fr/author/Xiao-Rong%20Liu", "affiliation": { "@type": "Organization", "name": "Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China." } }, { "@type": "Person", "name": "Yong-Hong Yi", "url": "https://questionsmedicales.fr/author/Yong-Hong%20Yi", "affiliation": { "@type": "Organization", "name": "Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China." } }, { "@type": "Person", "name": "Jie Wang", "url": "https://questionsmedicales.fr/author/Jie%20Wang", "affiliation": { "@type": "Organization", "name": "Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China." } }, { "@type": "Person", "name": "Wei-Ping Liao", "url": "https://questionsmedicales.fr/author/Wei-Ping%20Liao", "affiliation": { "@type": "Organization", "name": "Institute of Neuroscience, Department of Neurology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou, China." } }, { "@type": "Person", "name": "Na He", "url": "https://questionsmedicales.fr/author/Na%20He", "affiliation": { "@type": "Organization", "name": "Institute of Neuroscience and Department of Neurology of the Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510260, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Serum multi-cytokines screening identifies TRAIL and IL-10 as probable new biomarkers for prostate health index diagnostic utility adjustment in grey zone aggressive prostate cancer detection: A single-center data in China.", "datePublished": "2022-08-18", "url": "https://questionsmedicales.fr/article/36059480", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fimmu.2022.901176" } }, { "@type": "ScholarlyArticle", "name": "Efficacy and safety of switching from intravenous to oral antibiotics (amoxicillin-clavulanic acid) versus a full course of intravenous antibiotics in neonates with probable bacterial infection (RAIN): a multicentre, randomised, open-label, non-inferiority trial.", "datePublished": "2022-09-09", "url": "https://questionsmedicales.fr/article/36088952", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/S2352-4642(22)00245-0" } }, { "@type": "ScholarlyArticle", "name": "'I probably wouldn't want to talk about anything too personal': A qualitative exploration of how issues of privacy, confidentiality and surveillance in the home impact on access and engagement with online services and spaces for care-experienced young people.", "datePublished": "2023-10-19", "url": "https://questionsmedicales.fr/article/37873026", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1177/03085759231203019" } }, { "@type": "ScholarlyArticle", "name": "Modeling the Probability of HIV Infection over Time in High-Risk Seronegative Participants Receiving Placebo in Five Randomized Double-Blind Placebo-Controlled HIV Pre-Exposure Prophylaxis Trials: A Patient-Level Pooled Analysis.", "datePublished": "2022-08-27", "url": "https://questionsmedicales.fr/article/36145549", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3390/pharmaceutics14091801" } }, { "@type": "ScholarlyArticle", "name": "Risk and survival of patients with non-small cell lung cancer and pre-existing autoimmune disorders receiving immune checkpoint blockade therapy: Survival analysis with inverse probability weighting from a nationwide, multi-institutional, retrospective study (NEJ047).", "datePublished": "2024-07-14", "url": "https://questionsmedicales.fr/article/39029359", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.lungcan.2024.107894" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Maladies du système nerveux", "item": "https://questionsmedicales.fr/mesh/D009422" }, { "@type": "ListItem", "position": 3, "name": "Maladies du système nerveux central", "item": "https://questionsmedicales.fr/mesh/D002493" }, { "@type": "ListItem", "position": 4, "name": "Encéphalopathies", "item": "https://questionsmedicales.fr/mesh/D001927" }, { "@type": "ListItem", "position": 5, "name": "Épilepsie", "item": "https://questionsmedicales.fr/mesh/D004827" }, { "@type": "ListItem", "position": 6, "name": "Épilepsies partielles", "item": "https://questionsmedicales.fr/mesh/D004828" }, { "@type": "ListItem", "position": 7, "name": "Épilepsie partielle sensorielle", "item": "https://questionsmedicales.fr/mesh/D020937" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Épilepsie partielle sensorielle - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Épilepsie partielle sensorielle", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-17", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Épilepsie partielle sensorielle", "description": "Comment diagnostiquer l'épilepsie partielle sensorielle ?\nQuels tests sont utilisés pour confirmer le diagnostic ?\nLes antécédents familiaux influencent-ils le diagnostic ?\nQuels symptômes initiaux sont observés lors du diagnostic ?\nL'évaluation neurologique est-elle nécessaire ?", "url": "https://questionsmedicales.fr/mesh/D020937?mesh_terms=Probability&page=273#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Épilepsie partielle sensorielle", "description": "Quels sont les symptômes typiques de l'épilepsie partielle sensorielle ?\nLes crises affectent-elles la conscience ?\nPeut-on ressentir des odeurs ou des goûts étranges ?\nLes symptômes varient-ils d'une personne à l'autre ?\nLes crises peuvent-elles être déclenchées par des stimuli ?", "url": "https://questionsmedicales.fr/mesh/D020937?mesh_terms=Probability&page=273#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Épilepsie partielle sensorielle", "description": "Peut-on prévenir les crises d'épilepsie partielle sensorielle ?\nQuels sont les déclencheurs à éviter ?\nL'éducation des patients est-elle importante ?\nLe suivi médical régulier est-il nécessaire ?\nLes changements de mode de vie peuvent-ils aider ?", "url": "https://questionsmedicales.fr/mesh/D020937?mesh_terms=Probability&page=273#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Épilepsie partielle sensorielle", "description": "Quels traitements sont disponibles pour l'épilepsie partielle sensorielle ?\nLes médicaments antiépileptiques sont-ils efficaces ?\nLa chirurgie est-elle une option de traitement ?\nY a-t-il des effets secondaires aux traitements ?\nLes thérapies complémentaires sont-elles utiles ?", "url": "https://questionsmedicales.fr/mesh/D020937?mesh_terms=Probability&page=273#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Épilepsie partielle sensorielle", "description": "Quelles complications peuvent survenir avec l'épilepsie partielle sensorielle ?\nLes crises peuvent-elles entraîner des blessures ?\nY a-t-il un risque accru de dépression ?\nLes crises peuvent-elles affecter la vie quotidienne ?\nLes complications peuvent-elles être évitées ?", "url": "https://questionsmedicales.fr/mesh/D020937?mesh_terms=Probability&page=273#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Épilepsie partielle sensorielle", "description": "Quels sont les facteurs de risque de l'épilepsie partielle sensorielle ?\nLes traumatismes crâniens augmentent-ils le risque ?\nLes infections cérébrales sont-elles un facteur de risque ?\nL'âge joue-t-il un rôle dans le risque d'épilepsie ?\nLes troubles neurologiques augmentent-ils le risque ?", "url": "https://questionsmedicales.fr/mesh/D020937?mesh_terms=Probability&page=273#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer l'épilepsie partielle sensorielle ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique médical, l'EEG et l'imagerie cérébrale." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour confirmer le diagnostic ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'EEG et l'IRM sont essentiels pour identifier les anomalies cérébrales." } }, { "@type": "Question", "name": "Les antécédents familiaux influencent-ils le diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux d'épilepsie peuvent augmenter le risque." } }, { "@type": "Question", "name": "Quels symptômes initiaux sont observés lors du diagnostic ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des sensations anormales comme des picotements ou des hallucinations peuvent être signalées." } }, { "@type": "Question", "name": "L'évaluation neurologique est-elle nécessaire ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une évaluation neurologique complète est cruciale pour le diagnostic." } }, { "@type": "Question", "name": "Quels sont les symptômes typiques de l'épilepsie partielle sensorielle ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des sensations anormales, des picotements ou des hallucinations." } }, { "@type": "Question", "name": "Les crises affectent-elles la conscience ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Non, la conscience reste généralement intacte pendant les crises partielles sensorielles." } }, { "@type": "Question", "name": "Peut-on ressentir des odeurs ou des goûts étranges ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des sensations olfactives ou gustatives anormales peuvent survenir." } }, { "@type": "Question", "name": "Les symptômes varient-ils d'une personne à l'autre ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes peuvent varier considérablement selon les individus." } }, { "@type": "Question", "name": "Les crises peuvent-elles être déclenchées par des stimuli ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des stimuli comme la lumière ou le stress peuvent déclencher des crises." } }, { "@type": "Question", "name": "Peut-on prévenir les crises d'épilepsie partielle sensorielle ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La prévention passe par la gestion des déclencheurs et l'adhésion au traitement." } }, { "@type": "Question", "name": "Quels sont les déclencheurs à éviter ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Les déclencheurs incluent le stress, le manque de sommeil et certaines lumières clignotantes." } }, { "@type": "Question", "name": "L'éducation des patients est-elle importante ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'éducation aide les patients à reconnaître et éviter les déclencheurs." } }, { "@type": "Question", "name": "Le suivi médical régulier est-il nécessaire ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un suivi régulier permet d'ajuster le traitement et de surveiller les symptômes." } }, { "@type": "Question", "name": "Les changements de mode de vie peuvent-ils aider ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sain peut réduire la fréquence des crises." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour l'épilepsie partielle sensorielle ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des médicaments antiépileptiques et parfois la chirurgie." } }, { "@type": "Question", "name": "Les médicaments antiépileptiques sont-ils efficaces ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils sont souvent efficaces pour contrôler les crises chez de nombreux patients." } }, { "@type": "Question", "name": "La chirurgie est-elle une option de traitement ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la chirurgie peut être envisagée si les médicaments ne contrôlent pas les crises." } }, { "@type": "Question", "name": "Y a-t-il des effets secondaires aux traitements ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les médicaments peuvent avoir des effets secondaires comme la somnolence ou des vertiges." } }, { "@type": "Question", "name": "Les thérapies complémentaires sont-elles utiles ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Certaines thérapies comme la thérapie comportementale peuvent aider en complément." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec l'épilepsie partielle sensorielle ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent des blessures lors des crises et des troubles psychologiques." } }, { "@type": "Question", "name": "Les crises peuvent-elles entraîner des blessures ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les crises peuvent provoquer des chutes ou des blessures accidentelles." } }, { "@type": "Question", "name": "Y a-t-il un risque accru de dépression ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes épileptiques peuvent avoir un risque accru de dépression." } }, { "@type": "Question", "name": "Les crises peuvent-elles affecter la vie quotidienne ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent perturber les activités quotidiennes et la qualité de vie." } }, { "@type": "Question", "name": "Les complications peuvent-elles être évitées ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être évitées par un traitement approprié et un suivi." } }, { "@type": "Question", "name": "Quels sont les facteurs de risque de l'épilepsie partielle sensorielle ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent des antécédents familiaux, des traumatismes crâniens et des infections." } }, { "@type": "Question", "name": "Les traumatismes crâniens augmentent-ils le risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traumatismes crâniens peuvent augmenter le risque de développer l'épilepsie." } }, { "@type": "Question", "name": "Les infections cérébrales sont-elles un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des infections comme la méningite peuvent augmenter le risque d'épilepsie." } }, { "@type": "Question", "name": "L'âge joue-t-il un rôle dans le risque d'épilepsie ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'épilepsie peut survenir à tout âge, mais certains groupes d'âge sont plus à risque." } }, { "@type": "Question", "name": "Les troubles neurologiques augmentent-ils le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des troubles comme les AVC peuvent accroître le risque d'épilepsie." } } ] } ] }

Sources (2727 au total)

Serum multi-cytokines screening identifies TRAIL and IL-10 as probable new biomarkers for prostate health index diagnostic utility adjustment in grey zone aggressive prostate cancer detection: A single-center data in China.

To identify less invasive and easily applicable serum cytokine-derived biomarkers which contribute to the diagnostic utility and risk assessment ability of the prostate health index (PHI) based multiv... Serum 45 cytokines screening was performed in a small training cohort consisting of 10 sera by Luminex liquid array-based multiplexed immunoassays and identified TRAIL and IL-10 as new biomarkers for ... TRAIL and IL-10 were identified as potential serum biomarkers for AG PCa detection by the result of multi-cytokines screening in the univariate analysis, while multivariable logistic regression confir... We suggest a significant advantage for the PHI-based multivariate combinations of serum TRAIL and IL-10 comparing to PHI or other serum-derived biomarkers alone in the detection and risk stratificatio...

Efficacy and safety of switching from intravenous to oral antibiotics (amoxicillin-clavulanic acid) versus a full course of intravenous antibiotics in neonates with probable bacterial infection (RAIN): a multicentre, randomised, open-label, non-inferiority trial.

Switching from intravenous antibiotic therapy to oral antibiotic therapy among neonates is not yet practised in high-income settings due to uncertainties about exposure and safety. We aimed to assess ... In this multicentre, randomised, open-label, non-inferiority trial, patients were recruited at 17 hospitals in the Netherlands. Neonates (postmenstrual age ≥35 weeks, postnatal age 0-28 days, bodyweig... Between Feb 8, 2018 and May 12, 2021, 510 neonates were randomly assigned (n=255 oral amoxicillin-clavulanic group; n=255 intravenous antibiotic group). After excluding those who withdrew consent (n=4... An early intravenous-to-oral antibiotic switch with amoxicillin-clavulanic acid is non-inferior to a full course of intravenous antibiotics in neonates with probable bacterial infection and is not ass... The Netherlands Organization for Health Research and Development, Innovatiefonds Zorgverzekeraars, and the Sophia Foundation for Scientific Research....

'I probably wouldn't want to talk about anything too personal': A qualitative exploration of how issues of privacy, confidentiality and surveillance in the home impact on access and engagement with online services and spaces for care-experienced young people.

This paper draws on a qualitative interview-based study that explored online mental health and wellbeing interventions and services for care-experienced young people. The study involved young people (...

Risk and survival of patients with non-small cell lung cancer and pre-existing autoimmune disorders receiving immune checkpoint blockade therapy: Survival analysis with inverse probability weighting from a nationwide, multi-institutional, retrospective study (NEJ047).

The risk and survival of patients with non-small cell lung cancer (NSCLC) with pre-existing autoimmune disorders (AIDs) receiving immune checkpoint blockade (ICB) therapy have not been clearly establi... This multi-institutional, retrospective cohort study was conducted in collaboration with 20 centers in Japan.... In total, 229 patients with advanced or recurrent NSCLC and pre-existing AID, with or without ICB treatment from January 2010-February 2020, were included and analyzed. Among 69 patients who received ... These findings revealed a novel risk factor for AID flares following ICB treatment, that is the diagnosis of NSCLC within 1 year of AID diagnosis, and showed that ICBs may improve survival in this pop...

Mandibular dose-volume predicts time-to-osteoradionecrosis in an actuarial normal-tissue complication probability (NTCP) model: External validation of right-censored clinico-dosimetric and competing risk application across international multi-institutional observational cohorts and online graphical user interface clinical support tool assessment.

Existing studies on osteoradionecrosis of the jaw (ORNJ) have primarily used cross-sectional data, assessing risk factors at a single time point. Determining the time-to-event profile of ORNJ has impo... Demographic, clinical and dosimetric data were retrospectively obtained for a clinical observational cohort of 1129 patients with HNC treated with radiotherapy (RT) at The University of Texas MD Ander... Our model identified that each unit increase in D25% is significantly associated with a 12% shorter time to ORNJ (Adjusted Time Ratio [ATR] 0·88, p<0·005); pre-RT dental extractions was associated to ... This study is the first to demonstrate a direct relationship between radiation dose and the time to ORNJ onset, providing a novel characterization of the impact of delivered dose not only on the proba... This work was supported by various funding sources including NIH, NIDCR, NCI, NAPT, NASA, BCM, Affirmed Pharma, CRUK, KWF Dutch Cancer Society, NWO ZonMw, and the Apache Corporation....

The World Health Organization Antenatal CorTicosteroids for Improving Outcomes in preterm Newborns (ACTION-III) Trial: study protocol for a multi-country, multi-centre, double-blind, three-arm, placebo-controlled, individually randomized trial of antenatal corticosteroids for women at high probability of late preterm birth in hospitals in low- resource countries.

Preterm birth complications are the leading cause of newborn and under-5 mortality. Over 85% of all preterm births occur in the late preterm period, i.e. between 34 and < 37 weeks of gestation. Antena... WHO ACTION III trial is a parallel-group, three-arm, individually randomized, double-blind, placebo-controlled trial of two ACS regimens: dexamethasone phosphate 4 × 6 mg q12h or betamethasone phospha... This trial will evaluate the benefits and possible harms of ACS when used in women likely to have a late preterm birth. It will also evaluate a lower-dose ACS regimen based on literature from pharmaco... ISRCTN11434567 . Registered on 7 June 2021....